Related Experiment Video

Updated: Apr 8, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

22.5K

A mechanism for mineralocortcoid participation in renal disease and heart failure

Richard N Re1

  • 1Research Division, Ochsner Clinic Foundation, New Orleans, LA, USA.

Journal of the American Society of Hypertension : JASH
|June 24, 2015
PubMed

Insights

Chronic kidney disease and heart failure progress due to intracrine renin-angiotensin system (RAS) up-regulation, potentially interacting with mineralocorticoid activity. New insights suggest novel therapeutic targets for these progressive conditions.

Area of Science:

  • Nephrology
  • Cardiology
  • Endocrinology

Background:

  • Chronic renal disease and congestive heart failure often progress despite current treatments.
  • Renin-angiotensin system blockade and mineralocorticoid inhibition show partial efficacy.
  • Feed-forward intracrine loops, like renin-angiotensin system up-regulation, may drive disease progression.

Purpose of the Study:

  • To expand on the role of intracrine renin-angiotensin system up-regulation in disease progression.
  • To investigate the potential interaction between mineralocorticoid activity and intracrine renin-angiotensin system up-regulation.
  • To propose new therapeutic strategies based on these interactions.

Main Methods:

  • Review and expansion of existing clinical and physiological concepts.
  • Integration of data on renin-angiotensin system and mineralocorticoid pathways.
  • Theoretical modeling of intracrine loop interactions.

Main Results:

  • Proposed interaction between mineralocorticoid activity and intracrine renin-angiotensin system up-regulation.
  • Identification of intracrine loops as a key mechanism in disease progression.
  • Suggests potential for novel therapeutic interventions targeting these intracrine pathways.

Conclusions:

  • Intracrine renin-angiotensin system up-regulation, potentially modulated by mineralocorticoid activity, is a significant factor in chronic renal disease and heart failure progression.
  • Understanding these intracrine interactions offers a new perspective on disease pathophysiology.
  • This expanded view of intracrine physiology may guide the development of more effective treatments.
Keywords:
Aldosteroneangiotensinintracrine

More Related Videos

Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice07:36

Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice

Published on: September 26, 2018

10.6K
A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats07:31

A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats

Published on: December 2, 2016

10.8K

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.5K
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.2K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.5K
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
564
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.7K
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
2.7K